Indian Drug Discovery Informatics Market 2020 Analysis May Set New Growth Story, Forecast to 2026

Indian drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The rising investment in pharmaceutical R&D in the country encourages the demand for drug discovery informatics solutions among various contract research organizations and pharmaceutical companies. The companies in the country including Dr. Reddy’s Labs, Wockhardt, Advinus, Lupin, Cipla, Zydus Cadila, and many others have started investing in the R&D of small molecules with a novel mechanism of action. Drug Controller General of India (DCGI) is the regulatory body encouraging local Indian pharma companies to go deeper into innovation and development that is further projected to provide significant scope for the market.

To Request a Sample of our Report on Indian Drug Discovery Informatics Market:  https://www.omrglobal.com/request-sample/indian-drug-discovery-informatics-market

As per the India Brand Equity Foundation, the pharmaceutical R&D industry of India was valued at $26.1 billion in genetics in 2016 and the market is expected to be $55 billion by 2020. Around 304 Abbreviated New Drug Application (ANDA) approvals were received by India in 2017 from the US Food and Drug Administration (USFDA). The country accounts for around 30% by volume and nearly 10% by value in a $70-$80 billion US generics industry. Therefore, rising drug discovery related R&D in the country is projected to contribute considerably to the growth of the drug discovery informatics market in the near future. 

(Get 15% Discount on Buying this Report)

A full Report of Indian Drug Discovery Informatics Market is Available at:  https://www.omrglobal.com/industry-reports/indian-drug-discovery-informatics-market

Indian Drug Discovery Informatics Market – Segmentation

By Function

  • Docking
  • Molecular Modeling
  • Libraries and Database Preparation
  • Sequencing and Target Data Analysis
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others (Research Institutes) 

(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)